Lifeward Brings $22M Revenue, Reimbursed Robotics and an AI Pipeline to an $11.5M Market Cap (NASDAQ: LFWD)

AI SummaryClose X

Lifeward reported $22.0 million revenue in 2025, with its AlterG business generating $12.9 million and delivering year‑over‑year growth of 25% and 18% in the last two quarters, yet the company’s equity value was approximately $11.5 million at the November 13 close; third‑quarter revenue fell 12% to $5.4 million. Oramed holds ~44.2% and Lifeward secured up to $11.2 million in strategic financing, but the company remains loss‑making and must execute partner-based distribution and additional financing to monetize ReWalk’s Medicare reimbursement and fund an AI-enabled upper‑limb exoskeleton targeted for 2028.

Disclaimer*

UK 100

Latest directors dealings